June 17, 2026
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical care [...]
One million tubes, one unwavering commitment to sample integrity
June 16, 2026
Markes reaches manufacturing milestone after nearly three decades of supporting dependable analytical data worldwide For nearly three decades, Markes thermal desorption tubes have helped laboratories around the world generate dependable analytical data. The manufacture of the company's millionth tube marks an important milestone in that journey, reflecting the growth of thermal desorption as an analytical [...]
June 16, 2026
DURHAM, NC, USA and Cambridge, UK – Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CUT&RUN technology, today announced a partnership to help researchers generate high-confidence epigenomic insights faster. By combining EpiCypher’s CUTANA™ ChIC/CUT&RUN platform with Abcam’s expertise in antibody development and characterization, the collaboration [...]
June 16, 2026
New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates LAUSANNE, Switzerland and FREDERICK, Md., USA – Alithea Genomics today announced the early access launch of MERCURIUS™ 1536 DRUG-seq, a new ultra-high-throughput transcriptomics kit designed to help drug discovery teams profile compound-induced biological responses at true screening scale. The launch [...]
June 16, 2026
New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. JUPITER, Fla. -- TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing [...]
June 16, 2026
Improves Antibody Yield by About 10% in the Purification Process TOKYO and KYOTO -- FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) today announced the co-development of a high-sensitivity inline Raman measurement system*1 that enables continuous, real-time monitoring of component concentrations directly from bioreactor and process equipment during cell [...]
Leica Microsystems expands online shopping experience to Spain and Switzerland
June 16, 2026
Customers gain access to microscopy solutions, software, and localized purchasing options in their local languages Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, has expanded its online shopping experience to Spain and Switzerland, bringing an enhanced and localized digital store to customers in both countries. For the [...]
IDBS and Alchemi partner to accelerate biopharma regulatory filings with compliant AI agents
June 16, 2026
NEW YORK and WOKING, England -- IDBS, a Danaher company and leading provider of cloud software for biopharma, and Alchemi, a leading applied AI company serving the world's largest pharma and biotech development teams, today announced a partnership connecting AI agents to data captured and contextualized in the IDBS Polar platform across the drug development lifecycle. Preparing regulatory [...]
June 16, 2026
Improves Antibody Yield by About 10% in the Purification Process TOKYO & KYOTO, Japan -- FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) today announced the co-development of a high-sensitivity inline Raman measurement system*1 that enables continuous, real-time monitoring of component concentrations directly from bioreactor and process equipment [...]
Simulations Plus to Be Acquired by Altaris For Approximately $375 Million
June 16, 2026
Stockholders to Receive $18.50 Per Share in Cash Representing a 26% Premium to 60-day Volume-Weighted Average Price Transaction to Strengthen Simulations Plus and Accelerate Growth Through Anticipated Combination with Chemical Computing Group RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug [...]

